Delivery Order SPE2DR25D1100-SPE2DR26FCP2L
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,173.74 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on April 24, 2025, with an ultimate completion date of April 25, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,177.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, non-set-aside contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $16,000 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 28, 2025, with an ultimate completion date of October 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, represents a non-set-aside competitive procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,306.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order executed under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,082.81 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $4,560.54. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $17,455.88 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,519.86 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive, firm fixed-price delivery order was awarded on November 7, 2025, with an ultimate completion date of November 10, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCP2LDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,937.88 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The award was issued on November 13, 2025, with an ultimate completion date of November 14, 2025, and does not utilize a set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. military medical programs. The company's comprehensive pharmaceutical portfolio encompasses brand-name and generic medications, specialty drugs, vaccines, and related medical supplies across multiple therapeutic domains. The Eliquis delivery under this order represents a routine fulfillment of federal pharmaceutical procurement needs to support military and veteran healthcare systems. AmerisourceBergen's competitive positioning in federal medical procurement is evidenced by its extensive contract history with DLA and its ability to execute large-scale, competitively awarded delivery orders on an open basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 11/13/25 |